Company Profile

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01020Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE2148.3511.8 (+0.55 % )
PREV CLOSE (Rs.) 2136.55
OPEN PRICE (Rs.) 2151.90
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 4432
TODAY'S LOW / HIGH (Rs.)2139.45 2170.00
52 WK LOW / HIGH (Rs.)1467 2455.55
NSE2148.85 -3.4 (-0.16 % )
PREV CLOSE(Rs.) 2152.25
OPEN PRICE (Rs.) 2140.00
BID PRICE (QTY) 2148.85 (20 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 144487
TODAY'S LOW / HIGH(Rs.) 2137.05 2170.90
52 WK LOW / HIGH (Rs.)1466 2460

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.23
TTM EPS (Rs.) 88.06
P/E Ratio 24.40
Book Value (Rs.) 350.12
Face Value (Rs.) 2
MCap (Rs. in Mn) 272522.73
Price/Earning (TTM) 20.94
Price/Sales (TTM) 5.34
Price/Book (MRQ) 6.14
PAT Margin (%) 14.94
ROCE (%) 20.84
Incorporation Year : 1949

Management Info :

Premchand Godha - Chairman Premchand Godha - Managing Director

Registered Office :

Address : 48 , Kandivli Industrial Estate,Kandivli (West), ,
Mumbai,
Maharashtra-400067

Phone : 022- 66474444

Website : www.ipcalabs.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS More
09Apr04-09-2021$Ipca Laboratories informs about compliance certificate Ipca Laboratories informs ab
Ipca Laboratories has confirmed that activities in relation to both physical and electronic share transfer facility are maintained during the period October 1, 2020 to March 31, 2021 by the Company's Registrar and Share Transfer Agent, Link Intime India, which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number: INR000004058.

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories has confirmed that activities in relation to..
02Mar03-02-2021$ Goldman Sachs Is Hosting The Company Under
Its Annual India Pharma And Healthcare Tour 2021
Goldman Sachs Is Hosting Th
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Goldman Sachs is hosting the Company under its annual India Pharma and Healthcare Tour 2021 to a select set of global Investors comprising some of the largest sovereign funds, pension funds, large institutional investors, both foreign and domestic, to interact virtually with the Company''s management on Thursday, 4th March, 2021 between 10.30 a.m. to 11.30 a.m. Please note that in this virtual meeting, only publicly available information will be shared with the institutional investors. This is for your information/record.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and..
30Nov11-30-2020$Ipca Laboratories informs about disclosure Ipca Laboratories informs ab
Ipca Laboratories has informed that it has enclosed disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories has informed that it has enclosed disclosure..
27Oct10-27-2020$Ipca Laboratories to hold board meeting Ipca Laboratories to hold bo

Ipca Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 07/11/2020, to consider and take on record the Unaudited Financial Results for the 2nd quarter and half year ended 30th September, 2020 of the financial year 2020-21; and to consider declaration of Interim Dividend for the financial year 2020-21.

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories has informed that the meeting of the Board of..
18Sep09-18-2020$Ipca Laboratories informs about proceedings of 70th AGM Ipca Laboratories informs ab

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ipca Laboratories has informed that it has enclosed the proceedings at the 70th Annual General Meeting (AGM) of the Company held on 17th September, 2020.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of the Securities and Exchange Board..
Financials More
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit2599.76524.6
Gross Profit 3152.6 7849.7
Operating Profit 3644.89794.5
Net Sales 13152.243674.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Hester Biosciences (BSE)
 2470.05 (11.53%)
M.Cap ( in Cr)
2101.24
Astrazeneca Pharma I (BSE)
 3840.05 (2.70%)
M.Cap ( in Cr)
9600.13
Themis Medicare (BSE)
 497.30 (6.82%)
M.Cap ( in Cr)
456.94
Caplin Point Lab (BSE)
 591.05 (4.82%)
M.Cap ( in Cr)
4470.86
Glaxosmithkline Phar (BSE)
 1503.80 (1.65%)
M.Cap ( in Cr)
25475.28
Shareholding Pattern More
PROMOTERS 46.29 %
FI/BANKS/INSURANCE 3.64 %
MUTUAL FUNDS/UTI 20.85 %
NON-INSTITUTION 11.14 %
GOVERNMENT 0.28 %
FII 0 %
F & O Quotes